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Nursing Care of Clients with Upper 
Gastrointestinal Disorders 
 I. Care of Clients with Disorder of the Mouth 
                 A. Disorder includes inflammation, infection, 
neoplastic lesions 
 
                B. Pathophysiology 
                       1. Causes include mechanical trauma, irritants 
such as tobacco, chemotherapeutic agents 
                       2. Oral mucosa is relatively thin, has rich blood 
supply, exposed to environment 
                C. Manifestations 
1.  Visible lesions or erosions on lips or oral  mucosa 
 2.  Pain 
Nursing Care of Clients with Upper 
Gastrointestinal Disorders 
 D. Collaborative Care 
        1.Direct observation to investigate any problems; 
determine underlying cause and any coexisting diseases 
        2.Any undiagnosed oral lesion present for > 1 week and 
not responding to treatment should be evaluated for 
malignancy 
        3.General treatment includes mouthwashes or 
treatments to cleanse and relieve irritation 
             a.Alcohol bases mouthwashes cause pain and 
burning 
             b.Sodium bicarbonate mouthwashes are effective 
without pain 
       4. Specific treatments according to type of infection 
             a.Fungal (candidiasis): nystatin “swish and swallow” 
or clotrimazole lozenges  
          b.Herpetic lesions:  topical or oral acyclovir 
Nursing Care of Clients with Upper 
Gastrointestinal Disorders 
E. Nursing Care 
1. Goal: to relieve pain and symptoms, so client can 
continue food and fluid intake in health care facility 
and at home 
2. Impaired oral mucous membrane 
 a. Assess clients at high risk 
 b. Assist with oral hygiene post eating, bedtime 
 c. Teach to limit irritants: tobacco, alcohol, spicy 
foods 
3. Imbalanced nutrition: less than body requirements 
 a. Assess nutritional intake; use of straws 
 b. High calorie and protein diet according to client 
preferences 

Client with Oral Cancer 
 
1. Background 
a. Uncommon (5% of all cancers) but 
has high rate of morbidity, mortality 
b. Highest among males over age 40 
c. Risk factors include smoking and 
using oral tobacco, drinking alcohol, 
marijuana use, occupational exposure 
to chemicals, viruses (human papilloma 
virus) 
Client with Oral Cancer 
 
2. Pathophysiology 
 a. Squamous cell carcinomas 
 b. Begin as painless oral ulceration or 
lesion with irregular, ill-defined borders 
 c. Lesions start in mucosa and may 
advance to involve tongue, oropharynx, 
mandible, maxilla 
 d. Non-healing lesions should be evaluated 
for malignancy after one week of treatment 
Client with Oral Cancer 
 
3. Collaborative Care 
 a. Elimination of causative agents  
 b. Determination of malignancy with biopsy 
 c. Determine staging with CT scans and MRI 
 d. Based on age, tumor stage, general health 
and client’s preference, treatment may include 
surgery, chemotherapy, and/or radiation therapy 
 e. Advanced carcinomas may necessitate 
radical neck dissection with temporary or 
permanent tracheostomy;  Surgeries may be 
disfiguring 
 f. Plan early for home care post hospitalization, 
teaching family and client care involved post 
surgery, refer to American Cancer Society, 
support groups 
Client with Oral Cancer 
4. Nursing Care 
a. Health promotion: 
 1. Teach risk of oral cancer associated with all 
tobacco use and excessive alcohol use 
 2. Need to seek medical attention for all non-
healing oral lesions (may be discovered by dentists); 
early precancerous oral lesions are very treatable 
b. Nursing Diagnoses 
 1. Risk for ineffective airway clearance 
 2. Imbalanced Nutrition: Less than body 
requirements 
 3. Impaired Verbal Communication: establishment 
of specific communication plan and method should 
be done prior to any surgery 
 4. Disturbed Body Image 
Gastroesophageal Reflux Disease 
(GERD)  
1. Definition 
 b. GERD common, affecting 15 – 20% of 
adults 
 c. 10% persons experience daily heartburn 
and indigestion 
 d. Because of location near other organs 
symptoms may mimic other illnesses 
including heart problems 
 a. Gastroesophageal reflux is the backward 
flow of gastric content into the esophagus.   
Gastroesophageal Reflux Disease (GERD) 
2. Pathophysiology 
 a. Gastroesophageal reflux results from 
transient relaxation or incompetence of lower 
esophageal sphincter, or increased pressure 
within stomach 
 b. Factors contributing to gastroesophageal 
reflux  
        1.Increased gastric volume (post meals) 
        2.Position pushing gastric contents close to 
gastroesophageal  juncture (such as bending or 
lying down) 
        3.Increased gastric pressure (obesity or tight clothing) 
        4.Hiatal hernia 
Gastroesophageal Reflux Disease (GERD) 
 c.Normally the peristalsis in esophagus and 
bicarbonate in salivary secretions neutralize any 
gastric juices (acidic) that contact the esophagus; 
during sleep and with gastroesophageal reflux 
esophageal mucosa is damaged and inflamed; 
prolonged exposure causes ulceration, friable mucosa, 
and bleeding; untreated there is scarring and stricture 
3. Manifestations 
 a. Heartburn after meals, while bending over, or 
recumbent 
 b. May have regurgitation of sour materials in mouth, 
pain with swallowing 
 c. Atypical chest pain 
 d. Sore throat with hoarseness 




Gastroesophageal Reflux Disease 
(GERD) 
4. Complications 
 a. Esophageal strictures, which can progress to 
dysphagia 
 b. Barrett’s esophagus:  changes in cells lining 
esophagus with increased risk for esophageal 
cancer 
5. Collaborative Care 
 a. Diagnosis may be made from history of 
symptoms and risks 
 b. Treatment includes 
  1.Life style changes 
  2.Diet modifications 
  3.Medications 
Gastroesophageal Reflux Disease 
(GERD) 
6. Diagnostic Tests 
 a. Barium swallow (evaluation of 
esophagus, stomach, small intestine) 
 b. Upper endoscopy:  direct visualization; 
biopsies may be done 
 c. 24-hour ambulatory pH monitoring 
 d. Esophageal manometry, which measure 
pressures of esophageal sphincter and 
peristalsis 
 e.    Esophageal motility studies 

Gastroesophageal Reflux Disease 
(GERD) 
7. Medications 
 a. Antacids for mild to moderate symptoms, e.g. 
Maalox, Mylanta, Gaviscon 
 b. H2-receptor blockers:  decrease acid 
production; given BID or more often, e.g. 
cimetidine, ranitidine, famotidine, nizatidine 
 c. Proton-pump inhibitors: reduce gastric 
secretions, promote healing of esophageal 
erosion and relieve symptoms, e.g. omeprazole 
(prilosec); lansoprazole (Prevacid) initially for 8 
weeks; or 3 to 6 months 
 d. Promotility agent: enhances esophageal 
clearance and gastric emptying, e.g. 
metoclopramide (reglan) 
Gastroesophageal Reflux Disease 
8. Dietary and Lifestyle Management 
 a. Elimination of acid foods (tomatoes, spicy, citrus 
foods, coffee) 
 b. Avoiding food which relax esophageal sphincter 
or delay gastric emptying (fatty foods, chocolate, 
peppermint, alcohol) 
 c. Maintain ideal body weight 
 d. Eat small meals and stay upright 2 hours post 
eating; no eating 3 hours prior to going to bed 
 e. Elevate head of bed on 6 – 8 blocks to decrease 
reflux 
 f. No smoking 
 g. Avoiding bending and wear loose fitting clothing 
 
Gastroesophageal Reflux Disease 
(GERD) 
9. Surgery indicated for persons not 
improved by diet and life style changes 
a. Laparoscopic procedures to tighten 
lower esophageal sphincter 
b. Open surgical procedure:  Nissen 
fundoplication 
10. Nursing Care 
a. Pain usually controlled by treatment 





 a. Part of stomach protrudes through the 
esophageal hiatus of the diaphragm into 
thoracic cavity 
 b.     Predisposing factors include:   




Forced recumbent position 
 
Hiatal Hernia 
 c. Most cases are asymptomatic; incidence 
increases with age 
 d. Sliding hiatal hernia: gastroesophageal 
junction and fundus of stomach slide 
through the esophageal hiatus 
 e. Paraesophageal hiatal hernia: the 
gastroesophageal junction is in normal place 
but part of stomach herniates through 
esophageal hiatus; hernia can become 




2. Manifestations: Similar to GERD 
3. Diagnostic Tests 
 a. Barium swallow 
 b. Upper endoscopy 
4. Treatment  
 a. Similar to GERD:  diet and lifestyle changes, 
medications 
 b. If medical treatment is not effective or hernia 
becomes incarcerated, then surgery; usually Nissen 
fundoplication by thoracic or abdominal approach  
Anchoring the lower esophageal sphincter by wrapping a 
portion of the stomach around it to anchor it in place 

Impaired Esophageal Motility  
1. Types 
 a. Achalasia:  characterized by impaired peristalsis 
of smooth muscle of esophagus and impaired 
relaxation of lower esophageal sphincter 
 b. Diffuse esophageal spasm:  nonperistaltic 
contraction of esophageal smooth muscle 
2. Manifestations: Dysphagia and/or chest pain 
3. Treatment 
 a. Endoscopically guided injection of botulinum 
toxin 
Denervates cholinergic nerves in the distal 
esophagus to stop spams 
 b. Balloon dilation of lower esophageal sphincter 
May place stents to keep esophagus open 
Esophageal Cancer  
1. Definition: Relatively uncommon malignancy with 
high mortality rate, usually diagnosed late 
2. Pathophysiology 
 a. Squamous cell carcinoma  
  1.Most common affecting middle or distal portion 
of esophagus 
  2.More common in African Americans than 
Caucasians 
  3.Risk factors cigarette smoking and chronic 
alcohol use 
 b. Adenocarcinoma 
  1.Nearly as common as squamous cell affecting 
distal portion of esophagus 
  2.More common in  Caucasians 
  3.Associated with Barrett’s esophagus, 
complication of chronic GERD and achalasia  
Esophageal Cancer  
3. Manifestations 
 a. Progressive dysphagia with pain while 
swallowing 
 b. Choking, hoarseness, cough 
 c. Anorexia, weight loss 
4. Collaborative Care: Treatment goals  
 a. Controlling dysphagia 
 b. Maintaining nutritional status while 
treating carcinoma (surgery, radiation 
therapy, and/or chemotherapy 
Esophageal Cancer 
5. Diagnostic Tests 
 a. Barium swallow: identify irregular mucosal 
patterns or narrowing of lumen 
 b. Esophagoscopy: allow direct visualization 
of tumor and biopsy 
 c. Chest xray, CT scans, MRI: determine 
tumor metastases 
 d. Complete Blood Count: identify anemia 
 e. Serum albumin: low levels indicate 
malnutrition 
 f. Liver function tests:  elevated with liver 
metastasis 
Esophageal Cancer 
6. Treatments: dependent on stage of disease, 
client’s condition and preference 
 a. Early (curable) stage: surgical resection of 
affected portion with anastomosis of stomach to 
remaining esophagus; may also include 
radiation therapy and chemotherapy prior to 
surgery 
 b. More advanced carcinoma: treatment is 
palliative and may include surgery, radiation and 
chemotherapy to control dysphagia and pain 
 c. Complications of radiation therapy include 
perforation, hemorrhage, stricture 
Esophageal Cancer 
7. Nursing Care: Health promotion; education 
regarding risks associated with smoking and 
excessive alcohol intake 
8. Nursing Diagnoses 
 a. Imbalanced Nutrition: Less than body 
requirements (may include enteral tube feeding 
or parenteral nutrition in hospital and home) 
 b. Anticipatory Grieving (dealing with cancer 
diagnosis) 
 c. Risk for Ineffective Airway Clearance 
(especially during postoperative period if 
surgery was done) 
Peptic Ulcer Disease (PUD) 
Definition and Risk factors 
 a. Break in mucous lining of GI tract comes into 
contact with gastric juice; affects 10% of US 
population 
 b. Duodenal ulcers: most common; affect 
mostly males ages 30 – 55; ulcers found near 
pyloris 
 c. Gastric ulcers: affect older persons (ages 55 
– 70); found on lesser curvature and associated 
with increased incidence of gastric cancer 
 d. Common in smokers, users of NSAIDS; 
familial pattern, ASA, alcohol, cigarettes  
Peptic Ulcer Disease (PUD) 
2. Pathophysiology 
 A. Ulcers or breaks in mucosa of GI tract occur with  
  1. H. pylori infection (spread by oral to oral, 
fecal-oral routes) damages gastric epithelial cells 
reducing effectiveness of gastric mucus 
  2.Use of NSAIDS: interrupts prostaglandin 
synthesis which maintains mucous barrier of 
gastric mucosa 
 b. Chronic with spontaneous remissions and 
exacerbations associated with trauma, infection, 





Peptic Ulcer Disease 
Diagnosis 
Endoscopy with cultures 
Looking for H. Pylori 
Upper  GI barium contrast studies 
EGD-esophagogastroduodenoscopy 
Serum and stool studies 
 
برای ) محلول اوره(برای تست تنفسی مایعی :آزمایش تنفسی
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Peptic Ulcer Disease (PUD) 
3. Manifestations 
 a. Pain is classic symptom:  gnawing, 
burning, aching hungerlike in epigastric 
region possibly radiating to back; occurs 
when stomach is empty and relieved by food 
(pain: food: relief pattern) 
 b. Symptoms less clear in older adult; may 
have poorly localized discomfort, dysphagia, 
weight loss; presenting symptom may be 
complication: GI hemorrhage or perforation 
of stomach or duodenum 
Peptic Ulcer Disease 
Treatment 




• Neutralizes acids 
Proton pump inhibitors (omeprazole) 
• Block gastric acid secretion 
Peptic Ulcer Disease 
Pharmacological management 
Histamine blockers (Tagamet, Zantac) 
Blocks gastric acid secretion 
Carafate 
Forms protective layer over the site 
Mucosal barrier enhancers (bismuth 
subsalicylate , prostoglandins) 
Protect mucosa from injury 
Antibiotics(  نیسیامورتیرلاک،نیلکیسارتت و لوزادینورتم , 
نیلیس یسکومآ) 
Treat H. Pylori infection 
 
Peptic Ulcer Disease 
 Surgical intervention  
Minimally invasive gastrectomy 
Partial gastric removal with laproscopic surgery 
Bilroth I and II 
Removal of portions of the stomach 
Vagotomy 
Cutting of the vagus nerve to decrease acid 
secretion 
Pyloroplasty 





Peptic Ulcer Disease (PUD) 
4. Complications 
 a.Hemorrhage: frequent in older adult: hematemesis, 
melena, hematochezia (blood in stool); weakness, 
fatigue, dizziness, orthostatic hypotension and 
anemia; with significant bleed loss may develop 
hypovolemic shock 
 b.Obstruction: gastric outlet (pyloric sphincter) 
obstruction: edema surrounding ulcer blocks GI 
tract from muscle spasm or scar tissue 
  1.Gradual process 
  2.Symptoms: feelings of epigastric fullness, 
nausea, worsened ulcer symptoms 
 
Peptic Ulcer Disease 
 c.Perforation: ulcer erodes through mucosal 
wall and gastric or duodenal contents enter 
peritoneum leading to peritonitis; chemical at 
first  (inflammatory) and then bacterial in 6 to 
12 hours  
  1.Time of ulceration: severe upper 
abdominal pain radiating throughout 
abdomen and possibly to shoulder 
  2.Abdomen becomes rigid, boardlike with 
absent bowel sounds; symptoms of shock 
  3.Older adults may present with mental 
confusion and non-specific symptoms 
Upper GI Bleed 
Mortality approx 10% 
Predisposing factors include: drugs, 
esophageal varacies, esophagitis, PUD, 
gastritis and carcinoma 
Upper GI Bleed 
Signs and Symptoms 
Coffee ground vomitus 




Drop in Hct, Hgb 
Confusion 
syncope 
Upper GI Bleed 
Diagnosis 
History 
Blood, stool, vomitus studies 
Endoscopy 
 
Upper GI Bleed 
Treatments 
Volume replacement 




Endoscopic treatment of bleeding ulcer 
Sclerotheraphy-injecting bleeding ulcer with 
necrotizing agent to stop bleeding( ethanol amin) 
 
Upper GI Bleed 
Treatments 
Sengstaken-Blakemore tube 
Used with bleeding esophageal varacies 
Surgical intervention 
Removal of part of the stomach 
Sengstaken-Blakemore Tube 
Cancer of Stomach  
1. Incidence 
 a. Worldwide common cancer, but less common in 
US  
 b. Incidence highest among Hispanics, African 
Americans, Asian Americans, males twice as often 
as females 
 c. Older adults of lower socioeconomic groups 
higher risk 
2. Pathophysiology 
 a. Adenocarcinoma most common form involving 
mucus-producing cells of stomach in distal portion 
 b. Begins as localized lesion (in situ) progresses to 
mucosa; spreads to lymph nodes and metastasizes 
early in disease to liver, lungs, ovaries, peritoneum 
Cancer of Stomach 
3. Risk Factors 
 a. H. pylori infection 
 b. Genetic predisposition 
 c. Chronic gastritis, pernicious anemia, gastric 
polyps 
 d. Achlorhydria (lack of hydrochloric acid) 
 e. Diet high in smoked foods and nitrates 
4. Manifestations 
 a. Disease often advanced with metastasis when 
diagnosed 
 b. Early symptoms are vague: early satiety, anorexia, 
indigestion, vomiting, pain after meals not responding 
to antacids 
 c. Later symptoms weight loss, cachexia (wasted 
away appearance), abdominal mass, stool positive for 
occult blood 
Cancer of Stomach 
5. Collaborative Care 
  a.  Support client through testing 
  b.  Assist client to maintain adequate 
nutrition 
6. Diagnostic Tests 
  a.CBC indicates anemia 
  b.Upper GI series, ultrasound identifies a 
mass 
  c.Upper endoscopy:  visualization and 
tissue biopsy of lesion  
Cancer of Stomach 
7. Treatment 
 a. Surgery, if diagnosis made prior to 
metastasis 
  1.Partial gastrectomy with anastomosis to 
duodenum: Bilroth I or gastroduodenostomy 
  2.Partial gastrectomy with anastomosis to 
jejunum: Bilroth II or gastrojejunostomy 
  3.Total gastrectomy (if cancer diffuse but 
limited to stomach) with 
esophagojejunostomy 
Cancer of Stomach 
b. Complications associated with gastric surgery 
 1. Dumping Syndrome  
  a.Occurs with partial gastrectomy; hypertonic, 
undigested chyme bolus rapidly enters small 
intestine and pulls fluid into intestine causing 
decrease in circulating blood volume and increased 
intestinal peristalsis and motility 
  b.Manifestations 5 – 30 minutes after meal: 
nausea with possible vomiting, epigastric pain and 
cramping, borborygmi, and diarrhea; client becomes 
tachycardic, hypotensive, dizzy, flushed, diaphoretic 
  c.Manifestations 2 – 3 hours after meal: 
symptoms of hypoglycemia in response to excessive 
release of insulin that occurred from rise in blood 
glucose when chyme entered intestine 
Cancer of Stomach 
d. Treatment:  dietary pattern to delay gastric emptying 
and allow smaller amounts of chyme to enter 
intestine 
 1. Liquids and solids taken separately 
 2. Increased amounts of fat and protein 
 3. Carbohydrates, especially simple sugars, 
reduced 
 4. Client to rest recumbent or semi-recumbent 30 – 
60 minutes after eating 
 5. Anticholinergics(hyosin), sedatives, 
antispasmodic medications may be added(colofac) 
 6.     Limit amount of food taken at one time 
Cancer of the Stomach 











Cancer of Stomach 
 Nutritional problems related to rapid entry of food 
into the bowel and the shortage of intrinsic factor 
 1 Anemia:  iron deficiency and/or pernicious 
 2 Folic acid deficiency 
 3. Poor absorption of calcium, vitamin D 
c. Radiation and/or chemotherapy to control metastasic 
spread 
d. Palliative treatment including surgery, chemotherapy; 
client may have gastrostomy or jejunostomy tube 
inserted 
7. Nursing Diagnoses 
 a. Imbalanced Nutrition: Less than body 
requirement: consult dietician since client at risk for 
protein-calorie malnutrition 
 b. Anticipatory Grieving 
Diagnostic Evaluation 
 Lower GI tract studies:  
Barium Enema: detect polyps, tumors, lesions of colon 
Radiopaque substance instilled rectally 
Gastrografin (water-soluble iodine contrast) used in 
inflammatory disease or perforated colon 
 Nursing Interventions: May vary according to MD 
orders 
Bowel cleansing 1-2 days before, clear liquid diet 
day before, NPO after midnight, enema until clear 
morning of  
 Computed Tomography: cross-sectional images 
 Nursing Interventions: NPO for 6-8 hrs prior, assess 
for allergies to contrast dye  
 
Diagnostic Evaluation 
Magnetic Resonance Imaging: Noninvasive, uses 
magnetic fields and radio waves:  
Useful in evaluating soft tissues, vessels,neoplasm 
Contraindicated for pts with pacemakers, metal implants 
 Nursing Interventions: NPO for 6-8 hrs prior, remove 
all jewelry, procedure takes 30-90 minutes, close 
fitting scanner may cause feelings of claustrophobia  
 Anoscopy, Proctoscopy, Sigmoidoscopy:  
Viewing of lower colon through rigid or flexible 
scope 
 Nursing Interventions: Minimal bowel cleansing, 
monitor vital signs during and after procedure 
Diagnostic Evaluation 
 Colonoscopy: Direct visual inspection of colon to cecum  
Flexible fiberoptic colonoscope, can obtain biopsies and 
remove polyps 
Usually takes one hour, pt on left side, legs drawn toward 
chest 
 Nursing Interventions: May vary according to MD 
orders 
Bowel cleansing :clear liquids day before, 
Informed consent, NPO night before, IV 
midazolam (Versed) for sedation. 
During procedure monitor vital signs, O2 
saturation, color and temp of skin, level of 
consciousness, vagal response 
 
Gerontologic Considerations  
Oral Cavity 
Tooth loss or decay  .Atrophy of taste buds 
 Esophagus 
Weakened gag reflex 
 Stomach 
Decrease gastric secretions .Decrease motility 
 Small Intestine 
Atrophy of muscle and mucosal surfaces 
 Large Intestine 
Decrease mucus production 
Decrease tone of anal sphincter 
Nursing Care of Clients with Bowel 
Disorders 
   Factors affecting bodily function of elimination 
A. GI tract  
 1. Food intake 
 2. Bacterial flora in bowel 
B. Indirect 
 1. Psychologic stress 
 2. Voluntary postponement of defecation 
C. Normal bowel elimination pattern 
 1. Varies with the individual 
 2. 2 – 3 times daily to 3 stools per week 
 Irritable Bowel Syndrome (IBS) (spastic 
bowel, functional colitis) 
Definition 
a. Functional GI tract disorder without 
identifiable cause characterized by 
abdominal pain and constipation, diarrhea, 
or both 
b. Affects up to 20% of persons in 
Western civilization; more common in 
females 
Irritable Bowel Syndrome (IBS) 
(spastic bowel, functional colitis) 
Pathophysiology 
 a. Appears there is altered CNS regulation of 
motor and sensory functions of bowel 
  1.Increased bowel activity in response to 
food intake, hormones, stress 
  2.Increased sensations of chyme 
movement through gut 
  3.Hypersecretion of colonic mucus 
 b. Lower visceral pain threshold causing 
abdominal pain and bloating with normal 
levels of gas 
 c. Some linkage of depression and anxiety 
Irritable Bowel Syndrome (IBS) 
(spastic bowel, functional colitis) 
Manifestations 
 a. Abdominal pain relieved by defecation; may be 
colicky, occurring in spasms, dull or continuous 
 b. Altered bowel habits including frequency, hard 
or watery stool, straining or urgency with stooling, 
incomplete evacuation, passage of mucus; 
abdominal bloating, excess gas 
 c. Nausea, vomiting, anorexia, fatigue, headache, anxiety 
 d. Tenderness over sigmoid colon upon palpation 
4. Collaborative Care 
 a.  Management of distressing symptoms 
 b. Elimination of precipitating factors, stress 
reduction  
Irritable Bowel Syndrome (IBS) 
(spastic bowel, functional colitis) 
5. Diagnostic Tests: to find a cause for client’s abdominal 
pain, changes in feces elimination 
 a.Stool examination for occult blood, ova and parasites, 
culture 
 b.CBC with differential, Erythrocyte Sedimentation Rate 
(ESR): to determine if anemia, bacterial infection, or 
inflammatory process 
 c.Sigmoidoscopy or colonoscopy   
  1.Visualize bowel mucosa, measure intraluminal 
pressures, obtain biopsies if indicated 
  2.Findings with IBS: normal appearance increased 
mucus, intraluminal pressures, marked spasms, possible 
hyperemia without lesions 
 d.Small bowel series (Upper GI series with small bowel-
follow through) and barium enema: examination of entire 
GI tract; IBS: increased motility 
Irritable Bowel Syndrome (IBS) 
(spastic bowel, functional colitis) 
Medications 
 a. Purpose: to manage symptoms 
 b. Bulk-forming laxatives: reduce bowel spasm, 
normalize bowel movement in number and form 
 c. Anticholinergic drugs (dicyclomine (Bentyl), 
hyoscyamine) to inhibit bowel motility and prevent 
spasms; given before meals 
 d. Antidiarrheal medications (loperamide 
(Imodium), diphenoxylate (Lomotil): prevent 
diarrhea prophylactically 
 e. Antidepressant medications 
 f. Research: medications altering serotonin 
receptors in GI tract to stimulate peristalsis of the 
GI tract 
Irritable Bowel Syndrome (IBS) 
(spastic bowel, functional colitis) 
Dietary Management 
 a. Often benefit from additional dietary fiber: adds 
bulk and water content to stool reducing diarrhea 
and constipation 
 b. Some benefit from elimination of lactose, 
fructose, sorbitol 
 c. Limiting intake of gas-forming foods, caffeinated 
beverages 
8. Nursing Care 
 a. Contact in health environments outside acute 
care 
 b. Home care focus on improving symptoms with 
changes of diet, stress management, medications; 
seek medical attention if serious changes occur 
Peritonitis 
 Definition 
a. Inflammation of peritoneum, lining 
that covers wall (parietal peritoneum) 
and organs (visceral peritoneum) of 
abdominal cavity 
b. Enteric bacteria enter the peritoneal 
cavity through a break of intact GI tract 





Perforated bowel secondary to PUD 
Diverticulitis 







 a. Peritonitis results from contamination of 
normal sterile peritoneal cavity with 
infections or chemical irritant 
 b. Release of bile or gastric juices initially 
causes chemical peritonitis; infection occurs 
when bacteria enter the space 
 c. Bacterial peritonitis usually caused by 
these bacteria (normal bowel flora): 
Escherichia coli, Klebsiella, Proteus, 
Pseudomonas 
 d. Inflammatory process causes fluid shift 
into peritoneal space (third spacing); leading 
to hypovolemia, then septicemia 
Peritonitis 
3. Manifestations 
 a. Depends on severity and extent of 
infection, age and health of client 
 b. Presents with “acute abdomen” 
  1.Abrupt onset of diffuse, severe 
abdominal pain 
  2.Pain may localize near site of infection 
(may have rebound tenderness) 
  3.Intensifies with movement 
 c. Entire abdomen is tender with boardlike 
guarding or rigidity of abdominal muscle  
Peritonitis 
 d. paralytic ileus; 
  bowel sounds are diminished or absent  
 distention; nausea and vomiting 
 e. Systemically:  fever, malaise, tachycardia and 
tachypnea, restlessness, disorientation, oliguria 
with dehydration and shock 
 f. Older or immunosuppressed client may have 
  1.Few of classic signs 
  2.Increased confusion and restlessness 
  3.Decreased urinary output 
  4.Vague abdominal complaints 
  5.At risk for delayed diagnosis and higher   
             mortality rates  
Peritonitis 
4. Complications 
 a. mortality rate overall 40% 
 b. Abscess 
 c. Fibrous adhesions 
 d. Septicemia, septic shock; hypovolemic shock 
5. Collaborative Care 
 a. Diagnosis and identifying and treating cause 
 b. Prevention of complications 
Peritonitis 
6. Diagnostic Tests 
a. WBC with differential:  elevated WBC 
to 20,000; shift to left 
b. Blood cultures: identify bacteria in 
blood 
c. Liver and renal function studies, 
serum electrolytes: evaluate effects of 
peritonitis 
d. Abdominal xrays:  detect intestinal 
distension, air-fluid levels, free air under 
diaphragm (sign of GI perforation) 




  1.Broad-spectrum before definitive 
culture results identifying specific 
organism(s) causing infection 






 a. Laparotomy to treat cause (close 
perforation, removed inflamed tissue) 
 b. Peritoneal Lavage: washing out 
peritoneal cavity with copious amounts of 
warm isotonic fluid during surgery to dilute 
residual bacterial and remove gross 
contaminants 
 c. Often have drain in place and/or incision 
left unsutured to continue drainage  
Peritonitis 
9. Treatment 
 a. Intravenous fluids and electrolytes to 
maintain vascular volume and electrolyte 
balance 
 b. Bed rest in Fowler’s position to localize 
infection and promote lung ventilation 
 c. Intestinal decompression with nasogastric 
tube or intestinal tube connected to suction 
 1. Relieves abdominal distension secondary to 
paralytic ileus 
 2. NPO with intravenous fluids while having 
nasogastric suction 
Peritonitis 
10. Nursing Diagnoses 
 a. Pain 
 b. Deficient Fluid Volume: often on hourly output; 
nasogastric drainage is considered when ordering 
intravenous fluids 
 c. Ineffective Protection 
 d. Anxiety 
11. Home Care 
 a. Client may have prolonged hospitalization 
 b. Home care often includes 
 1. Wound care 
 2. Home health referral 
 3. Home intravenous antibiotics 
 اندازه گیری فشارخون به وسیله یک خط شریانی در صورت بروز شوک 
اندازه گیری و ثبت دقیق میزان مایعات دریافتی ودفعی واندازه گیری فشار ورید 
 مرکزی برای جایگزینی صحیح مایعات  
 بررسی مداوم درد،علائم حیاتی،عملکرد گوارشی و تعادل مایعات و الکترولیتها
بیمار به پهلو خوابانده شود در حالی که )قرار دادن بیمار در وضعیت مناسب 
زانوها خمیده هستند این وضعیت باعث کاستن از فشار وارده بر اندامهای شکمی 
 .می شود
کاهش تب و تعداد نبض،نرم شدن )به محض فروکش کردن علایم پریتونیت
به تدریج مایعات و ( شکم،برگشت صداهای روده،دفع گاز و شروع حرکات روده
 .غذای خوراکی آغاز می شود و میزان مایعات وریدی کاهش میابد
 آماده کردن بیمار برای یک جراحی فوری درصورت بدتر شدن وضعیت بیمار 
  مشاهده وثبت دقیق مشخصات ترشحات درن
 
  Neoplastic Disorders  
Background 
1. Large intestine and rectum most 
common GI site affected by cancer 
2. Colon cancer is second leading cause of 
death from cancer in U.S. 
B. Client with Polyps 
1. Definition 
a. Polyp is mass of tissue arising from 
bowel wall and protruding into lumen 
b. Most often occur in sigmoid and rectum 
c. 30% of people over 50 have polyps 
Neoplastic Disorders 
Pathophysiology 
a. Most polyps are adenomas, 
benign but considered 
premalignant; < 1% become 
malignant but all colorectal cancers 
arise from these polyps 
b. Familial polyposis is uncommon 
autosomal dominant genetic 
disorder with hundreds of 
adenomatous polyps throughout 
large intestine; untreated, near 100% 
malignancy by age 40 
Client with Polyps 
 
Manifestations 
 a. Most asymptomatic 
b. Intermittent painless rectal bleeding is 
most common presenting symptom 
Collaborative Care 
 a. Diagnosis is based on colonoscopy 
b. Most reliable since allows inspection 
of entire colon with biopsy or 
polypectomy if indicated 
c. Repeat every 3 years since polyps 
recur 
Client with Polyps 
 
Nursing Care 
a. All clients advised to have 
screening colonoscopy at age 50 
and every 5 years thereafter 
b. Bowel preparation ordered prior 
to colonoscopy with cathartics 
and/or enemas 
Polyps 
Client with Colorectal Cancer 
Definition 
a. Third most common cancer 
diagnosed 
b. Affects sexes equally 
c. Five-year survival rate is 90%, with 
early diagnosis and treatment  
Risk Factors 
a. Family history 
b. Inflammatory bowel disease 
c. Diet high in fat, calories, protein 
% 59 -گرفتاری زیر مخاطی– Iپیش آگهی مرحله 
 .است
 -گرفتاری تا غشاء مخاطی– IIپیش آگهی مرحله 
 .است% 08
 -گرفتاری غدد لنفاوی– IIIپیش آگهی مرحله 
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Client with Colorectal Cancer 
Manifestations 
a. Often produces no symptoms 
until it is advanced 
b. Presenting manifestation is 
bleeding; also change in bowel 
habits (diarrhea or constipation); 
pain, anorexia, weight loss, 
palpable abdominal or rectal mass; 
anemia 
Colon Cancer 
Client with Colorectal Cancer 
Complications 
a. Bowel obstruction 
b. Perforation of bowel by tumor, peritonitis 
c. Direct extension of cancer to adjacent 
organs; reoccurrences within 4 years 
Screening 
a. Digital exam beginning at age 40, annually 
b. Fecal occult blood testing beginning at 
age 50, annually 
c. Colonoscopies or sigmoidoscopies 
beginning at age 50, every 3 – 5 years 
Client with Colorectal Cancer 
Diagnostic Tests 
 a. CBC:  anemia from blood loss, tumor growth 
 b. Fecal occult blood (guiac or Hemoccult 
testing): all colorectal cancers bleed intermittently 
 
 c. Carcinoembryonic antigen (CEA): not used as 
screening test, but is a tumor marker and used to 
estimate prognosis, monitor treatment 
  
 d. Colonoscopy or sigmoidoscopy; tissue biopsy 
of suspicious lesions, polyps 
 e. Chest xray, CTscans, MRI, ultrasounds: to 
determine tumor depth, organ involvement, 
metastasis 
Client with Colorectal Cancer 
Pre-op care 
Consult with ET nurse if ostomy is planned 
Bowel prep with GoLytely 
NPO 
NG 
Client with Colorectal Cancer 
Surgery 
 a. Surgical resection of tumor, adjacent 
colon, and regional lymph nodes is treatment 
of choice 
 b. Whenever possible anal sphincter is 
preserved and colostomy avoided; 
anastomosis of remaining bowel is performed 
 c. Tumors of rectum are treated with 
abdominoperineal resection (A-P resection) in 
which sigmoid colon, rectum, and anus are 
removed through abdominal and perineal 
incisions and permanent colostomy created 
Client with Colorectal Cancer 
Colostomy  
1.  Named for area of colon is which formed 
 a. Sigmoid colostomy: used with 
abdominoperineal  resection formed on LLQ 
 b. Double-barrel colostomy: 2 stomas: proximal 
for feces diversion; distal is mucous fistula 
 c. Transverse loop colostomy: emergency 
procedure; loop suspended over a bridge; 
temporary 
 d. Hartman procedure: Distal portion is left in 
place and oversewn; only proximal colostomy is 
brought to abdomen as stoma; temporary; colon 
reconnected at later time when client ready for 
surgical repair 
 






• Should be pink and moist 
• Dark red or black indicates ischemic 
necrosis 
• Look for excessive bleeding 
• Observe for possible separation of suture 
securing stoma to abdominal wall 
Client with Colorectal Cancer 
Post-op care 
Evaluate stool after 2-4 days postop 
Ascending stoma (right side) 




• Normal, solid stool 
 مشاهده دهانه ایلئوستومی از نظر رنگ و اندازه 
 ساعت بعد از عمل آغاز شود 27دفع مدفوع از ایلئوستومی باید 
 اندازه گیری مایع جمع شده
 تحرک بیمار
 اندازه گیری و ثبت مایعات دریافتی و دفعی
 روز 4_5محلول های وریدی برای جبران مایعات به مدت 
 ساکشن بینی معدی با هدف خارج کردن مایع و گاز معده و شستشوی مرتب آن
 .تهوع ونفخ شکم ممکن است نشان دهنده ی انسداد روده باشد
 برداشتن پانسمان داخلی رکتوم در پایان هفته اول
 بار در روز 2_3شستشوی ناحیه ی پرینه 
 اقدامات حمایتی مناسب
 آموزش تعویض کیسه
 روز  5_7تعویض کیسه هر 
 استفاده از غذاهایی مثل اسفناج و جعفری برای کنترل بوی کیسه
 استفاده از داروهای ضد اسهال خوراکی
 هفته  6_8ادامه رژیم غذایی بیمار به صورت کم باقی مانده برای 





 اولویت های مراقبت پرستاری شامل آماده سازی جسمی بیمار و ارائه اطلاعات لازم
 رژیم غذایی پرپروتئین و پر کالری و کم باقی مانده
 ساعت قبل از عمل 42_84رژیم غذایی مایع از 
 استفاده از آنتی بیوتیک ها بخصوص سفالکسین
 .در شب قبل از عمل و صبح روز جراحی  استفاده از مسهل ها و تنقیه
 سوند بینی معدی 
 آموزش تمرینات تنفسی عمیق
 فراهم کردن یک محیط خصوصی برای بیمار
 ملاقات با یک فرد روحانی




نشت از محل آناستاموز، پرولاپس استوما، سوراخ : بررسی مداوم از نظرعوارض      
 شدن استوما، تشکیل توده سخت مدفوع
 بررسی شکم از نظر برگشت حرکات دودی     
 کمک به بیمار برای خروج از تخت در اولین روز بعد از عمل     
 داشتن رژیم غذایی متناسب با شرایط ، پرهیز از غذاهایی که     
 بو و گاز زیادی تولید می کنندو غذاهای ایجاد کننده اسهال     
 در صورت یبوست آب آلو یا سیب یا یک ملین خفیف موثر است     
 لیتر مایع در روز2لیوان یا  21مصرف حداقل      
 کنترل مرتب پانسمان جراحی از نظر خونریزی      
 به بیمار کمک شود در صورت سرفه و تنفس عمیق روی خط بخیه را ثابت نگه دارد     
 افزایش درجه حرارت و نبض و تنفس که نشانه یک فرایند عفونی است مرتبا کنترل شود     
بررسی مرتب صدا های روده ای ،کنترل علائم حیاتی بیمار و بررسی خونریزی از       
 .رکتوم و اندازه گیری هموگلوبین و هماتوکریت 
بررسی و کنترل عوارض ریوی با تغییر وضعیت مناسب بیمار و تنفس عمیق و سرفه       
 .کردن هرچه سریعتر RBRو 
 recnaC noloC
End stoma with Hartmann’s  pouch 





 انواع لوله ها
 nivel.1
  (ژژنوم درو  تغذیه روده اي) pnuS.2
  (برداشتن فشار و شستشو (tuobar ailliM.3
 )gninrub munedoed(rotnaC.4
 )ساكشن و شستشو(sirraH.5
 
cholecystitis 
به مجموعه اتساع،ادم،ایسکمی،التهاب و  sititsycelohc
عفونت ثانویه کیسه صفرا گفته می شود و 
عمدتا ناشی از انسداد کیستیک توسط سنگ 




علامت اصلی بروز درد ناگهانی در قسمت 
 فوقانی شکم
 تهوع و استفراغ             
 بی اشتهایی                   
 تب خفیف 
 علامت مورفی              
 تغییر رنگ ادرار و مدفوع   




















 تغییرات مکرر در وزن
 از دست دادن سریع وزن
 درمان با استروژن زیاددیابت قندی 
 sititsycelohc
التهاب مزمن دیواره کیسه صفرا تقریبا همیشه با وجود سنگ صفرا همراه است و تصور 
می شود در اثر دوره های متعدد کله سیستیت حاد یا تحت حاد یا از تحریکات مکانیکی 
% 52مداوم  دیواره کیسه صفرا توسط سنگ های کیسه صفرا ناشی می شود در بیش ار 




 کوله سیستکتومی  با لاپاراسکوپی: درمان جراحی 
  کوله سیستکتومی                  
  کولدوکوستومی                  
  کوله سیستوستومی به روش جراحی                  
  کوله سیستوستومی از راه پوست                 
 sititsycelohc
 مطالعات پرتو نگاری از کیسه صفرا 
 عکس قفسه سینه،
 نوار قلب
 .آزمون های کارکرد کبد
 .بر طرف کردن نیاز های تغذیه ای 
آموزش درباره تنفس عمیق و تغییر 
 . پوزیشن
دادن اطلاعات لازم درباره ی لوله های 
 تخلیه، لوله معده و دستگاه ساکشن
 
 sititsycelohc
 نشستهقرار دادن بیمار در وضعیت نیمه  
 تجویز مایعات داخل وریدی
 ساکشن نازوگاستریک
 ساعت بعد از عمل جراحی 42نوشیدن مایعات 




       
 sititsycelohc
 درد و ناراحتی در رابطه با برش جراحی
اختلال در تبادل گازها در رابطه با برش جراحی روی 
 قسمت های فوقانی شکم
 اختلال در سلامت پوست در رابطه با تغییر در تخلیه صفرا 
اختلالات تغذیه ای کمتر از نیاز های بدن در رابطه با 
 ترشح ناکافی صفرا
 اطلاعات ناکافی درباره نحوه مراقبت از خود
 
متداول ترین کاربرد برداشتن طحال زمانی است که طحال پاره     
شده باشد و موجب خونریزی شدید شود در این شرایط انجام 
پر کاری طحال . اسپلنکتومی یک پروسیجر اورژانسی است
دومین کاربرد مهم مهم برداشت طحال است و باعث می شود 















 خطر بروز عفونت
 احتمال بروز عوارض به دنبال برداشتن طحال
 کمبود اطلاعات و تدابیر غیر موثر رژیم درمانی
 
 بررسی علایم ونشانه های عفونت
 اقداماتی در جهت پیشگیری از عفونت 
 پیشگیری از احتمال بروز عوارض بدنبال اسپلنکتومی
 The end 
 Client with Intestinal Obstruction 
Definition  
 a. May be partial or complete obstruction 
 b. Failure of intestinal contents to move 
through the bowel lumen; most common site 
is small intestine 
 c. With obstruction, gas and fluid 
accumulate proximal to and within 
obstructed segment causing bowel 
distention 
 d. Bowel distention, vomiting, third-spacing 
leads to hypovolemia, hypokalemia, renal 
insufficiency, shock 
Client with Intestinal Obstruction 
Pathophysiology 
a. Mechanical 
1. Problems outside intestines: adhesions (bands 
of scar tissue), hernias 
2. Problems within intestines: tumors, IBD 
3. Obstruction of intestinal lumen (partial or 
complete) 
 a. Intussusception: telescoping bowel 
 b. Volvulus: twisted bowel 
 c. Foreign bodies 
 d. Strictures 
Client with Intestinal Obstruction 
Functional 
1. Failure of peristalsis to move intestinal contents: 
adynamic ileus (paralytic ileus, ileus) due to 
neurologic or muscular impairment 
2. Accounts for most bowel obstructions 
3. Causes include 
 a. Post gastrointestinal surgery 
 b. Tissue anoxia or peritoneal irritation from 
hemorrhage, peritonitis, or perforation 
 c. Hypokalemia 
 d. Medications: narcotics, anticholinergic 
drugs, antidiarrheal medications 
 e.  Spinal cord injuries, uremia, alterations in 
electrolytes 
Client with Intestinal Obstruction 
      Manifestations Small Bowel Obstruction 
a. Vary depend on level of obstruction and speed of 
development 
b. Cramping or colicky abdominal pain, intermittent, 
intensifying 
c. Vomiting 
 1. Proximal intestinal distention stimulates vomiting 
center 
 2. Distal obstruction vomiting may become feculent 
d. Bowel sounds 
 1. Early in course of mechanical obstruction: 
borborygmi and high-pitched tinkling, may have visible 
peristaltic waves 
 2. Later silent; with paralytic ileus, diminished or 
absent bowel sounds throughout 
e. Signs of dehydration 
Client with Intestinal Obstruction 
Complications 
 a. Hypovolemia and hypovolemic shock can 
result in multiple organ dysfunction (acute 
renal failure, impaired ventilation, death) 
 b. Strangulated bowel can result in 
gangrene, perforation, peritonitis, possible 
septic shock 
 c. Delay in surgical intervention leads to 
higher mortality rate 
Client with Intestinal Obstruction 
Large Bowel Obstruction 
 a. Only accounts for 15% of obstructions 
 b. Causes include cancer of bowel, 
volvulus, diverticular disease, inflammatory 
disorders, fecal impaction 
 c. Manifestations: deep, cramping pain; 
severe, continuous pain signals bowel 
ischemia and possible perforation; localized 
tenderness or palpable mass may be noted 
Client with Intestinal Obstruction 
Collaborative Care 
 a. Relieving pressure and obstruction 
 b. Supportive care 
Diagnostic Tests 
a. Abdominal Xrays and CT scans with contrast media  
 1. Show distended loops of intestine with fluid and /or gas in small 
intestine, confirm mechanical obstruction; indicates free air under 
diaphragm  
 2. If CT with contrast media meglumine diatrizoate (Gastrografin), 
check for allergy to iodine, need BUN and Creatinine to determine 
renal function 
b. Laboratory testing to evaluate for presence of infection and electrolyte 
imbalance: WBC, Serum amylase, osmolality, electrolytes, arterial 
blood gases 
c. Barium enema or colonoscopy/sigmoidoscopy to identify large bowel 
obstruction 
Gastrointestinal Decompression 
 a. Treatment with nasogastric or long intestinal tube provides 
bowel rest and removal of air and fluid 
 b. Successfully relieves many partial small bowel obstructions 
Client with Intestinal Obstruction 
Surgery 
 a. Treatment for complete mechanical obstructions, 
strangulated or incarcerated obstructions of small bowel, 
persistent incomplete mechanical obstructions 
 b. Preoperative care 
 1. Insertion of nasogastric tube to relieve vomiting, 
abdominal distention, and to prevent aspiration of 
intestinal contents 
 2. Restore fluid and electrolyte balance; correct acid 
and alkaline imbalances 
 3. Laparotomy:  inspection of intestine and removal of 
infarcted or gangrenous tissue 
 4. Removal of cause of obstruction: adhesions, tumors, 
foreign bodies, gangrenous portion of intestines and 
anastomosis or creation of colostomy depending on 
individual case 
Client with Intestinal Obstruction 
Nursing Care 
 a. Prevention includes healthy diet, fluid intake 
 b. Exercise, especially in clients with recurrent 
small bowel obstructions 
Nursing Diagnoses 
 a. Deficient Fluid Volume 
 b. Ineffective Tissue Perfusion, gastrointestinal 
 c. Ineffective Breathing Pattern 
Home Care 
 a. Home care referral as indicated 
 b. Teaching about signs of recurrent obstruction 
and seeking medical attention 
Client with Diverticular Disease 
Definition 
 a. Diverticula are saclike projections of mucosa 
through muscular layer of colon mainly in 
sigmoid colon 
 b. Incidence increases with age; less than a 
third of persons with diverticulosis develop 
symptoms 
Risk Factors 
 a. Cultural changes in western world with diet 
of highly refined and fiber-deficient foods 
 b. Decreased activity levels 
 c. Postponement of defecation 
Client with Diverticular Disease 
Pathophysiology 
 a. Diverticulosis is the presence of diverticula 
which form due to increased pressure within 
bowel lumen causing bowel mucosa to herniate 
through defects in colon wall, causing 
outpouchings 
 b. Muscle in bowel wall thickens narrowing 
bowel lumen and increasing intraluminal 
pressure 
 c. Complications of diverticulosis include 
hemorrhage and diverticulitis, the inflammation 
of the diverticular sac 
 
Clients with Diverticular Disease 
d. Diverticulitis:  diverticulum in 
sigmoid colon irritated with undigested 
food and bacteria forming a hard mass 
(fecalith) that impairs blood supply 
leading to perforation 
e. With microscopic perforation, 
inflammation is localized; more 
extensive perforation may lead to 
peritonitis or abscess formation 
Diverticulits 
Diverticulitis 
Client with Diverticular Disease 
Manifestations 
 a. Pain, left-sided, mild to moderate and cramping 
or steady 
 b. Constipation or frequency of defecation 
 c. May also have nausea, vomiting, low-grade 
fever, abdominal distention, tenderness and palpable 
LLQ mass 
 d. Older adult may have vague abdominal pain 
Complications 
 a. Peritonitis 
 b. Abscess formation 
 c. Bowel obstruction 
 d. Fistula formation 
 e. Hemorrhage 
Client with Diverticular Disease 
Collaborative Care: Focus is on management of 
symptoms and complications 
Diagnostic Tests 
 a. Abdominal Xray:  detection of free air with 
perforation, location of abscess, fistula 
 b. Barium enema contraindicated in early 
diverticulitis due to risk of barium leakage into 
peritoneal cavity, but will confirm diverticulosis 
 c. Abdominal CT scan, sigmoidoscopy or 
colonscopy used in diagnosis of diverticulosis 
 d. WBC count with differential: leukocytosis with 
shift to left in diverticulitis 
 e. Hemocult or guiac testing: determine presence 
of occult blood  
Client with Diverticular Disease 
Medications 
 a. Broad spectrum antibiotics against gram negative 
and anaerobic bacteria to treat acute diverticulitis, oral or 
intravenous route depending on severity of symptoms 
 Flagyl plus Bactrim or Cipro 
 b. Analgesics for pain (non-narcotic) 
 c.     Fluids to correct dehydration 
 d. Stool softener but not cathartic may be prescribed 
(nothing to increase pressure within bowel) 
 e.     Anticholinergics to decrease intestinal hypermotility 
Clients with Diverticular Disease 
Dietary Management 
a. Diet modification may decrease risk 
of complications 
b. High-fiber diet (bran, commercial 
bulk-forming products such as psyllium 
seed (Metamucil) or methycelluose) 
c. Some clients advised against foods 
with small seeds which could obstruct 
diverticula 
 
Client with Diverticular Disease 
Treatment for acute episode of diverticulitis 
 a. Client initially NPO with intravenous fluids 
(possibly TPN) 
 b. As symptoms subside reintroduce food:  clear 
liquid diet, to soft, low-roughage diet psyillium seed 
products to soften stool and increase bulk 
 c. High fiber diet is resumed after full recovery 
Surgery 
 a. Surgical intervention indicated for clients with 
generalized peritonitis or abscess that does not 
respond to treatment 
 b. With acute infection, 2 stage Hartman procedure 
done with temporary colostomy; re-anastomosis 
performed 2 – 3 months later 
Client with Diverticular Disease 
Nursing Care: Health promotion includes teaching 
high-fiber foods in diet generally, may be 
contraindicated for persons with known conditions 
Nursing Diagnoses 
 a. Impaired Tissue Integrity, gastrointestinal 
 b. Pain 
 c. Anxiety, related to unknown outcome of 
treatment, possible surgery 
Home Care 
 a. Teaching regarding prescribed diet, fluid intake, 
medications 
 b. Referral for home health care agency, if new 
colostomy client  
